Clinical Trial Update: The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessed the efficacy of galantamine in improving attention in patients with Alzheimer's disease, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-12-24